At 6.3x GenOn's (GEN +25.8%) estimated 2013 EBITDA, NRG's (NRG +8.3%) merger with GenOn was completed at an attractive price, Wunderlich says; ~$200M of operating cost savings are expected, with an additional $100M of interest and capital cost savings. Barclays upgrades NRG to Overweight with a $22 price target, up from $19. (also)
Are you Bullish or Bearish on ?
Results for ()
Thanks for sharing your thoughts.
From other sites
at Zacks.com (Fri, 2:06PM)
at Zacks.com (Fri, 9:04AM)
at Zacks.com (Wed, 10:50AM)
at Nasdaq.com (Jan 28, 2015)
at CNBC.com (Jan 12, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs